LPNT - LifePoint Health, Inc.

YHD - YHD Delayed Price. Currency in USD
At close: 6:07PM EDT
Stock chart is not supported by your current browser
Previous CloseN/A
YTD ReturnN/A
Expense Ratio (net)N/A
CategoryN/A
Last Cap GainN/A
Morningstar RatingN/A
Morningstar Risk RatingN/A
Sustainability RatingN/A
Net AssetsN/A
Beta (5Y Monthly)N/A
YieldN/A
5y Average ReturnN/A
Holdings TurnoverN/A
Last DividendN/A
Average for CategoryN/A
Inception DateN/A
  • Moody's

    LifePoint Health, Inc. -- Moody's assigns B1 to LifePoint Health's new senior secured notes

    Moody's Investors Service ("Moody's") today assigned a B1 rating to LifePoint Health, Inc.'s ("LifePoint") new senior secured notes. There is no impact on any of LifePoint's existing ratings, including the B2 corporate family rating, B1 senior secured rating, and Caa1 senior unsecured rating, or the stable outlook.

  • Moody's

    LifePoint Health, Inc. -- Moody's: LifePoint's refinancing will meaningfully reduce interest expense

    Moody's Investors Service commented that LifePoint Health, Inc.'s ("LifePoint") refinancing transaction is credit positive because it will enable the company to meaningfully reduce its interest expense and lengthen its maturity profile. This publication does not announce a credit rating action. For any credit ratings referenced in this publication, please see the ratings tab on the issuer/entity page on www.moodys.com for the most updated credit rating action information and rating history.

  • Moody's

    LifePoint Health, Inc. -- Moody's announces completion of a periodic review of ratings of LifePoint Health, Inc.

    Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of LifePoint Health, Inc. New York, October 02, 2019 -- Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of LifePoint Health, Inc. and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers.